Clinical Trial Update: A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel [Phase 1]

View source ↗

Summary

Phase I study of the oral platinum agent satraplatin in combination with weekly docetaxel for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• satraplatin (satraplatin)

Snippet

Sponsor: Agennix | Conditions: Tumors, Prostate Cancer | Phase 1 | Status: TERMINATED